The current challenge in cell therapies lies in the inefficient delivery of genes to target cells, resulting in costly manufacturing processes. This project aims to identify and validate small molecule viral sensitizers (VSEs) that enhance the efficiency of cell therapy production. These VSEs will streamline the manufacturing process, making cell therapies more accessible and cost-effective. […]
Read More